Phaco linked to posterior capsule rupture

Article

Phacoemulsification is linked to a higher rate of posterior capsule rupture in vitrectomized eyes, compared to combined vitrectomy and cataract surgery.

Phacoemulsification is linked to a higher rate of posterior capsule rupture in vitrectomized eyes, compared to combined vitrectomy and cataract surgery, claimed a paper in Retina.

Dr Jong Yeon Lee et al., Department of Ophthalmology, Gachon University Gil Hospital, Incheon, Korea, retrospectively reviewed the medical records of 54 patients who underwent cataract surgery in eyes that had previously been vitrectomized and 311 patients who experienced combined vitrectomy and cataract surgery. The main primary outcome measure was intraoperative complications during phacoemulsification and the secondary measures were preoperative and intraoperative cataract gradings.

It was discovered that the most common complication during phacoemulsification was posterior capsule rupture. The rate was higher in the sequential group than in the combined group, as was preoperative lens density.

Hard nucleus cataracts in vitrectomized eyes could have caused the higher rate of posterior capsule rupture in the sequential group.

Please click here for the abstract.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.